Funding of US biomedical research, 2003-2008

E. Ray Dorsey, Jason De Roulet, Joel P. Thompson, Jason I. Reminick, Ashley Thai, Zachary White-Stellato, Christopher A. Beck, Benjamin P. George, Hamilton Moses

Research output: Contribution to journalArticle


Context: With the exception of the American Recovery and Reinvestment Act, funding support for biomedical research in the United States has slowed after a decade of doubling. However, the extent and scope of slowing are largely unknown. Objective: To quantify funding of biomedical research in the United States from 2003 to 2008. Design: Publicly available data were used to quantify funding from government (federal, state, and local), private, and industry sources. Regression models were used to compare financial trends between 1994-2003 and 2003-2007. The numbers of new drug and device approvals by the US Food and Drug Administration over the same period were also evaluated. Main Outcome Measures: Funding and growth rates by source; numbers of US Food and Drug Administration approvals. Results: Biomedical research funding increased from $75.5 billion in 2003 to $101.1 billion in 2007. In 2008, funding from the National Institutes of Health and industry totaled $88.8 billion. In 2007, funding from these sources, adjusted for inflation, was $90.2 billion. Adjusted for inflation, funding from 2003 to 2007 increased by 14%, for a compound annual growth rate of 3.4%. By comparison, funding from 1994 to 2003 increased at an annual rate of 7.8% (P

Original languageEnglish (US)
Pages (from-to)137-143
Number of pages7
JournalJournal of the American Medical Association
Issue number2
Publication statusPublished - Jan 13 2010
Externally publishedYes


ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dorsey, E. R., De Roulet, J., Thompson, J. P., Reminick, J. I., Thai, A., White-Stellato, Z., ... Moses, H. (2010). Funding of US biomedical research, 2003-2008. Journal of the American Medical Association, 303(2), 137-143.